Life Sciences Review has awarded Andira Pharmaceuticals the Top Therapeutic & Medical Device Products Provider 2023, and feature Andira in the August 17, 2023 issue with CEO, Dana Lambert, PhD on the cover.
The article written by Jeremy Williams, begins, “The healthcare sector eagerly anticipates the next chapter of innovation in standard-of-care therapies, characterized by remarkable advancements in effectiveness and safety. Despite the ongoing efforts, unmet needs in medical practice continue to persist, especially when it comes to addressing widespread medical conditions like hospital-acquired infection (HAI) and metastatic cancers, both difficult to treat.
Andira Pharmaceuticals has emerged as a beacon of hope with its novel adjunctive therapies that use natural compounds to accelerate the delivery of treatment. The preclinical and clinical stage health science company leverages cannabinoids, a remarkable class of natural compounds found in the cannabis sativa plant that hold significant potential of both safety and therapeutic efficacy.